Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Deals & Financings

VC fundings, mergers and acquisitions, and other financing events...

Junshi Bio Completes $50 Million Investment in US Partner, Coherus

Porton Biologics Raises $61 Million for Cell/Gene Therapy CDMO Services

Sinopharm to Transfer Six Vaccine Companies (Including Two Covid-19 Vaccines) to Beijing Tiantan Bio

Qilu In-Licenses Preclinical ADC Candidate from Korea's Peptron

Ocumension Acquires Implant Therapy for Retina Diseases in $119 Million Deal

Upcoming event
Shanghai and Digital
May 10-14, 2021
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
The Ritz-Carlton Shanghai Pudong
March 23-25, 2021